Mayinglong Pharmaceutical Group Co Ltd

Price Chart

Risk-Adjusted Performance

Mayinglong Pharmaceutical Group Co Ltd (600993) Price Performance

Mayinglong Pharmaceutical Group Co Ltd (600993) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY24.76, down 1.32% from the previous close.

Over the past year, 600993 has traded between a low of CNY24.76 and a high of CNY31.00. The stock has lost 7.5% over this period. It is currently 20.1% below its 52-week high.

Mayinglong Pharmaceutical Group Co Ltd has a market capitalization of $10.67B, with a price-to-earnings ratio of 18.62 and a dividend yield of 2.47%.

About Mayinglong Pharmaceutical Group Co Ltd

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as well as automobile freight services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; provision of hospital and medical management service; and hospital operations. Further, it imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Compare Mayinglong Pharmaceutical Group Co Ltd

Side-by-side comparison against top Healthcare peers.